The meta-analysis demonstrated that a low level of MUC2 expression was associated with large tumors compared to small tumors in patients with CRC (RR, 1.32; 95% CI, 1.02–1.70; P = 0.03; Figure 3(e)). Here, MUC2 is linked to colorectal carcinoma.